Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
St. Erik Eye Hospital
The Swedish Society of Medicine (SLS-971390)
The Royal Swedish Academy of Sciences (ME2019-0036)
Cancerfonden (20 0798 Fk)
Region Stockholm (RS-2019-1138)
The Swedish Eye Foundation (2022-05-02)
Karolinska Institutet (FS-2021-0010)
Karolinska Institute
- License Information
-
More Information
Article History
Received: 5 October 2022
Accepted: 13 March 2023
First Online: 26 March 2023
Declarations
:
: The trial is going to be performed according to the trial protocol, CTR regarding human medicine (536/2014), Helsinki Declaration, ICH-GCP, and the current national regulation relevant to this clinical trial. EU-trial number: 2022–500307-49–00. The trial is approved by The Swedish Medical Products Agency and The Swedish Ethical Review Authority.Signed informed consent forms will be obtained from all trial participants (see the “” section for more information).
: Not applicable.
: The authors declare that they have no competing interests.
